We describe the restructured OpenAI arrangement in structural terms only: royalty-free access to frontier-model IP through 2032, a revenue share through 2030, an equity stake, and OpenAI as a large compute customer across our AI accelerators. The filing reflects net recognized equity-method losses. OpenAI is material to the backlog — commercial RPO grew 26% year-over-year excluding it — but no percentage is disclosed. An outside claim of 45% of Azure RPO appears in no filing or call. Whether we ever quantify that share remains an open question.